Exodus Point Capital Management, LP Ovid Therapeutics Inc. Transaction History

Exodus Point Capital Management, LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$1.43 - $1.89 $19,150 - $25,310	13,392 New	13,392 $25,000
Q4 2021 Feb 11, 2022	SELL	$3.13 - $3.73 $61,006 - $72,701	-19,491 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$3.31 - $4.04 $114,009 - $139,153	-34,444 Reduced 63.86%	19,491 $65,000
Q2 2021 Aug 16, 2021	BUY	$3.3 - $4.49 $177,985 - $242,168	53,935 New	53,935 $211,000
Q4 2020 Feb 16, 2021	SELL	$2.28 - $6.84 $33,199 - $99,597	-14,561 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$5.39 - $8.24 $78,483 - $119,982	14,561 New	14,561 $84,000
Q2 2020 Aug 14, 2020	SELL	$2.67 - $7.91 $134,987 - $399,905	-50,557 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$2.03 - $4.35 $197,281 - $422,746	-97,183 Reduced 65.78%	50,557 $151,000
Q4 2019 Feb 14, 2020	BUY	$2.08 - $5.06 $307,299 - $747,564	147,740 New	147,740 $613,000

39.2M

10.3K

200

Ticker OVID
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,419,400
Market Cap $79.6M
Description
Ovid Therapeutics Inc., a biopharmaceutical company, develops impactful medicines for patients and families with neurological disorders in the United States. The company is developing OV101, a drug candidate, which is in Phase 2A clinical trials for the treatment of fragile X syndrome; OV329, a GABA aminotransferase inhibitor for the treatment o...

Get notified when there are updates to the investment portfolio of Exodus Point Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Exodus Point Capital Management, LP with notifications on news.